233 related articles for article (PubMed ID: 33298520)
1. Characterization of Vixotrigine, a Broad-Spectrum Voltage-Gated Sodium Channel Blocker.
Hinckley CA; Kuryshev Y; Sers A; Barre A; Buisson B; Naik H; Hajos M
Mol Pharmacol; 2021 Jan; 99(1):49-59. PubMed ID: 33298520
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Pharmacokinetic Interaction Between the Voltage- and Use-Dependent Nav1.7 Channel Blocker Vixotrigine and Carbamazepine in Healthy Volunteers.
Dunbar J; Versavel M; Zhao Y; Tate S; Morisset V; Giblin GMP; Palmer J; Tidemann-Miller B; Naik H
Clin Pharmacol Drug Dev; 2020 Jan; 9(1):62-73. PubMed ID: 31650711
[TBL] [Abstract][Full Text] [Related]
3. A novel isoquinoline alkaloid HJ-69 isolated from Zanthoxylum bungeanum attenuates inflammatory pain by inhibiting voltage-gated sodium and potassium channels.
Wang L; Hao H; Meng X; Zhang W; Zhang Y; Chai T; Wang X; Gao Z; Zheng Y; Yang J
J Ethnopharmacol; 2024 Aug; 330():118218. PubMed ID: 38677570
[TBL] [Abstract][Full Text] [Related]
4. PF-06526290 can both enhance and inhibit conduction through voltage-gated sodium channels.
Wang L; Zellmer SG; Printzenhoff DM; Castle NA
Br J Pharmacol; 2018 Jul; 175(14):2926-2939. PubMed ID: 29791744
[TBL] [Abstract][Full Text] [Related]
5. Purification and Characterization of a Novel Insecticidal Toxin, μ-sparatoxin-Hv2, from the Venom of the Spider
Xiao Z; Zhang Y; Zeng J; Liang S; Tang C; Liu Z
Toxins (Basel); 2018 Jun; 10(6):. PubMed ID: 29880771
[TBL] [Abstract][Full Text] [Related]
6. Modulatory effects of bufalin, an active ingredient from toad venom on voltage-gated sodium channels.
Tao J; Jiang F; Liu C; Liu Z; Zhu Y; Xu J; Ge Y; Xu K; Yin P
Mol Biol Rep; 2018 Oct; 45(5):721-740. PubMed ID: 29931533
[TBL] [Abstract][Full Text] [Related]
7. Purification and Characterization of JZTx-14, a Potent Antagonist of Mammalian and Prokaryotic Voltage-Gated Sodium Channels.
Zhang J; Tang D; Liu S; Hu H; Liang S; Tang C; Liu Z
Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30308978
[TBL] [Abstract][Full Text] [Related]
8. Effects of a State- and Use-Dependent Nav1.7 Channel Blocker on Ambulatory Blood Pressure: A Randomized, Controlled Crossover Study.
Fong R; Ballow CH; Naik H; Steiner D; Palmer J; White WB
J Clin Pharmacol; 2019 Jan; 59(1):90-97. PubMed ID: 30144099
[TBL] [Abstract][Full Text] [Related]
9. Enhancing inactivation rather than reducing activation of Nav1.7 channels by a clinically effective analgesic CNV1014802.
Zheng YM; Wang WF; Li YF; Yu Y; Gao ZB
Acta Pharmacol Sin; 2018 Apr; 39(4):587-596. PubMed ID: 29094728
[TBL] [Abstract][Full Text] [Related]
10. Identification of WB4101, an
Li M; Wu Y; Zou B; Wang X; Li M; Yu H
Mol Pharmacol; 2018 Aug; 94(2):896-906. PubMed ID: 29884692
[TBL] [Abstract][Full Text] [Related]
11. The Selective Nav1.7 Inhibitor, PF-05089771, Interacts Equivalently with Fast and Slow Inactivated Nav1.7 Channels.
Theile JW; Fuller MD; Chapman ML
Mol Pharmacol; 2016 Nov; 90(5):540-548. PubMed ID: 27587537
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic Characterization of LTGO-33, a Selective Small Molecule Inhibitor of the Voltage-Gated Sodium Channel Na
Gilchrist JM; Yang ND; Jiang V; Moyer BD
Mol Pharmacol; 2024 Feb; 105(3):233-249. PubMed ID: 38195157
[TBL] [Abstract][Full Text] [Related]
13. Loperamide inhibits sodium channels to alleviate inflammatory hyperalgesia.
Wu Y; Zou B; Liang L; Li M; Tao YX; Yu H; Wang X; Li M
Neuropharmacology; 2017 May; 117():282-291. PubMed ID: 28216001
[TBL] [Abstract][Full Text] [Related]
14. Biphasic voltage-dependent inactivation of human Na
Godazgar M; Zhang Q; Chibalina MV; Rorsman P
J Physiol; 2018 May; 596(9):1601-1626. PubMed ID: 29441586
[TBL] [Abstract][Full Text] [Related]
15. Licochalcone Mediates the Pain Relief by Targeting the Voltage-Gated Sodium Channel.
Zhao Q; Zhang X; Long S; Wang S; Yu H; Zhou Y; Li Y; Xue L; Hu Y; Yin S
Mol Pharmacol; 2023 Oct; 104(4):133-143. PubMed ID: 37419692
[TBL] [Abstract][Full Text] [Related]
16. The peptide toxin δ-hexatoxin-MrIX inhibits fast inactivation of Na
Tang D; Xiao Z; Xu Y; Zeng J; Peng D; Liang S; Tang C; Liu Z
Peptides; 2018 Apr; 102():47-53. PubMed ID: 29501398
[TBL] [Abstract][Full Text] [Related]
17. Modulation of peripheral Na(+) channels and neuronal firing by n-butyl-p-aminobenzoate.
Thériault O; Poulin H; Sculptoreanu A; de Groat WC; O'Leary ME; Chahine M
Eur J Pharmacol; 2014 Mar; 727():158-66. PubMed ID: 24486399
[TBL] [Abstract][Full Text] [Related]
18. Voltage-gated sodium channel function and expression in injured and uninjured rat dorsal root ganglia neurons.
Yin R; Liu D; Chhoa M; Li CM; Luo Y; Zhang M; Lehto SG; Immke DC; Moyer BD
Int J Neurosci; 2016; 126(2):182-92. PubMed ID: 25562420
[TBL] [Abstract][Full Text] [Related]
19. Antidepressants inhibit Na
Horishita T; Yanagihara N; Ueno S; Okura D; Horishita R; Minami T; Ogata Y; Sudo Y; Uezono Y; Sata T; Kawasaki T
Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec; 390(12):1255-1270. PubMed ID: 28905186
[TBL] [Abstract][Full Text] [Related]
20. Analgesic Effects of Topical Amitriptyline in Patients With Chemotherapy-Induced Peripheral Neuropathy: Mechanistic Insights From Studies in Mice.
Genevois AL; Ruel J; Penalba V; Hatton S; Petitfils C; Ducrocq M; Principe P; Dietrich G; Greco C; Delmas P
J Pain; 2021 Apr; 22(4):440-453. PubMed ID: 33227509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
